TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million June 21, 1974
TCL Archive Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE October 4, 2002